SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,619 | -29.8% | 90,774 | 0.0% | 0.00% | – |
| Q2 2023 | $103,482 | -23.3% | 90,774 | +0.9% | 0.00% | – |
| Q1 2023 | $134,979 | +86.1% | 89,986 | +84.8% | 0.00% | – |
| Q4 2022 | $72,535 | +27.3% | 48,681 | +31.9% | 0.00% | – |
| Q3 2022 | $57,000 | +50.0% | 36,906 | +118.8% | 0.00% | – |
| Q2 2022 | $38,000 | -65.5% | 16,871 | -64.9% | 0.00% | – |
| Q1 2022 | $110,000 | -24.7% | 48,001 | +91.7% | 0.00% | – |
| Q4 2021 | $146,000 | +62.2% | 25,034 | +194.0% | 0.00% | – |
| Q3 2021 | $90,000 | -21.7% | 8,514 | -27.1% | 0.00% | – |
| Q2 2021 | $115,000 | -43.1% | 11,675 | -16.4% | 0.00% | – |
| Q1 2021 | $202,000 | – | 13,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $231,000 | 0.01% |
| FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
| UBS Group AG | 13,618 | $31,000 | 0.00% |
| RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
| Ellevest, Inc. | 19 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
| FMR LLC | 179 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |